Dementia in other diseases classified elsewhere, unspecified severity, with anxiety
ICD-10 F02.84 is a billable code used to indicate a diagnosis of dementia in other diseases classified elsewhere, unspecified severity, with anxiety.
F02.84 refers to dementia that occurs as a result of other diseases classified elsewhere, such as Parkinson's disease, Huntington's disease, or multiple sclerosis. This code is specifically used when the severity of dementia is unspecified and is accompanied by anxiety symptoms. Dementia is characterized by a decline in cognitive function, affecting memory, thinking, and social abilities, which can interfere with daily life. The presence of anxiety can exacerbate cognitive symptoms, leading to increased confusion, agitation, and behavioral changes. Cognitive assessments, such as the Mini-Mental State Examination (MMSE) or Montreal Cognitive Assessment (MoCA), are essential for evaluating the extent of cognitive impairment. Behavioral symptoms may include mood swings, irritability, and withdrawal from social interactions. Caregiver support is crucial, as caregivers often face significant stress and need resources to manage both the patient’s dementia and their own well-being.
Detailed neurological assessments, cognitive testing results, and documentation of anxiety symptoms.
Patients with dementia due to Parkinson's disease presenting with anxiety and cognitive decline.
Neurologists must ensure comprehensive documentation of both cognitive and behavioral symptoms to support coding.
Mental health evaluations, treatment plans addressing anxiety, and documentation of cognitive assessments.
Patients with dementia experiencing significant anxiety impacting their daily functioning.
Psychiatrists should document the interplay between dementia and anxiety to justify the use of F02.84.
Used to assess cognitive function in patients with dementia and anxiety.
Results of cognitive assessments must be documented.
Neurologists and psychologists should collaborate on documentation.
Documenting anxiety is crucial as it can significantly impact the patient's cognitive function and overall quality of life. It also helps in tailoring treatment plans and justifying the use of specific codes like F02.84.
